CLINICAL_TRIALS
trial_result
· 2019-10-14
Clinical Trial Update: Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome [Phase 3]
Summary
A Phase 3 trial investigating cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) for fibromyalgia syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fundació Sant Joan de Déu | Conditions: Fibromyalgia Syndrome | Phase 3 | Status: COMPLETED